Clinical trial
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health…
NCT00141518 · AbbVie (prior sponsor, Abbott), Industry · Completed
Key facts
| NCT number | NCT00141518 |
|---|---|
| Title | Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact |
| Official title | A Long-term Health Economics Study of Intraduodenal Levodopa (Duodopa®) in Routine Care for Patients With Advanced Idiopathic Parkinson's Disease With Severe Motor Fluctuations and Hyper-/Dyskinesia |
| Acronym | DAPHNE |
| Lead sponsor | AbbVie (prior sponsor, Abbott), Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Advanced Idiopathic Parkinson's Disease |
| Intervention type | Device, Drug |
| Interventions | Levodopa-carbidopa intestinal gel (LCIG), CADD-Legacy® 1400 ambulatory infusion pump, percutaneous endoscopic gastrostomy tube (PEG tube), jejunal extension tube (J-tube) |
| Enrollment | 77 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Sep 1, 2005 |
| Last update posted | Jul 18, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: